FP7 UK Technology Strategy Board Driving Innovation An Introduction to EU funding Manchester– 24 th June 2013 Octavio Pernas - FP7UK National Contact Point for Health

FP7 UK Technology Strategy Board Driving Innovation Competitiveness and Innovation Programme (CIP) Framework Programme (Horizon 2020) Eurostars Innovative Medicines Initiative (IMI) Health Programme European & Developing Countries Clinical Trials Partnership (EDCTP) Structural Funds Ambient Assisted Living Other schemes EU funding for Research and Innovation

FP7 UK Technology Strategy Board Driving Innovation Horizon 2020 structure Opportunities for SMEs Facts and figures NCP support Agenda

FP7 UK Technology Strategy Board Driving Innovation Horizon 2020 structure Opportunities for SMEs Facts and figures NCP support Agenda

FP7 UK Technology Strategy Board Driving Innovation All aspects are under discussion, thus subject to change

FP7 UK Technology Strategy Board Driving Innovation Horizon 2020: What is it? Commission proposal for a 80 billion euro research and innovation funding programme ( ) A core part of Europe 2020, Innovation Union & European Research Area: Responding to the economic crisis to invest in future jobs and growth Addressing people’s concerns about their livelihoods, safety and environment Strengthening the EU’s global position in research, innovation and technology Horizon 2020 structure

FP7 UK Technology Strategy Board Driving Innovation A single programme bringing together three separate programmes/initiatives (FP, EIT, CIP) More support for innovation activities Strong focus on creating business opportunities Focus on societal challenges facing EU society International cooperation Simplified access for all participants Horizon 2020: What is new? Horizon 2020 structure

FP7 UK Technology Strategy Board Driving Innovation 1.Excellent science 2.Industrial leadership 3.Societal challenges Horizon 2020: Three priorities Horizon 2020 structure

FP7 UK Technology Strategy Board Driving Innovation Industrial Leadership  Leadership in enabling and industrial technologies  Access to risk finance  Innovation in SMEs Excellent Science  European Research Council (ERC)  Future and Emerging Technologies (FET)  Marie Curie Actions  Research infrastructures Shared objectives and principles Common rules, toolkit of funding schemes Societal Challenges  Health, demographic change and well-being  Food security, sustainable agriculture, marine and maritime research, and the bio-economy  Secure, clean and efficient energy  Smart, green and integrated transport  Climate action, resource efficiency and raw materials  Inclusive, innovative and secure societies  EIT

FP7 UK Technology Strategy Board Driving Innovation Horizon 2020 structure Opportunities for SMEs Facts and figures NCP support Agenda

FP7 UK Technology Strategy Board Driving Innovation Single set of simpler and more coherent participation rules. New balance between trust and control. Single funding rates (100 % for research projects; 70 % for activities closer to market) Replacing the four methods to calculate overhead or "indirect costs" with a single flat rate. Major simplification under the forthcoming financial regulation Successful applicants to get working more quickly: reduction of average time to grant by 100 days (currently 350 days) Opportunities for SMEs Simplification - summary

FP7 UK Technology Strategy Board Driving Innovation All forms of R&D and all forms of innovation, towards exploitation and commercialisation SME participation in Societal challenges and Innovative Medicines Initiative (IMI) collaborative projects SME instrument Access to risk finance (debt and equity facility) Innovation in start-ups, spin-offs and young companies (Eurostars and other measures) Exchange and mobility of researchers involving SMEs (new Marie Curie actions) Opportunities for SMEs Activities for SMEs - overview

FP7 UK Technology Strategy Board Driving Innovation 1. Understanding health, wellbeing and disease 1.1. Understanding the determinants of health, improving health promotion and disease prevention 1.2. Understanding disease 1.3. Improving surveillance and preparedness 2. Preventing disease 2.1. Developing effective prevention and screening programmes and improving the assessment of disease susceptibility 2.2. Improving diagnosis and prognosis 2.3. Developing better preventive and therapeutic vaccines Opportunities for SMEs Activities for SMEs – Health challenge

FP7 UK Technology Strategy Board Driving Innovation 3. Treating and managing disease 3.1. Treating disease, including developing regenerative medicine 3.2. Transferring knowledge to clinical practice and scalable innovation actions 4. Active ageing and self-management of health 4.1. Active ageing, independent and assisted living 4.2. Individual awareness and empowerment for self-management of health Opportunities for SMEs Activities for SMEs – Health challenge

FP7 UK Technology Strategy Board Driving Innovation 5. Methods and data 5.1. Improving health information and better use of health data 5.2. Improving scientific tools and methods to support policy making and regulatory needs 5.3 Using in-silico medicine for improving disease management and prediction 6. Health care provision and integrated care 6.1. Promoting integrated care 6.2. Optimising the efficiency and effectiveness of healthcare provision Opportunities for SMEs Activities for SMEs – Health challenge

FP7 UK Technology Strategy Board Driving Innovation Targeted at all types of innovative SMEs Only SMEs allowed to apply for funding (single company support possible) Competitive Market-oriented, EU dimension Bottom-up while addressing societal challenges and/or key enabling technologies SME-friendly rules and procedures Opportunities for SMEs Activities for SMEs – SME instrument

FP7 UK Technology Strategy Board Driving Innovation New SME instrument Phase 1 Concept & Feasibility Assessment Phase 2 Demonstration Market Replication R&D Phase 3 Commercialisation Feasibility of concept Risk assessment IP regime Partner search Design study Development, prototype, test Miniaturisation / design Clinical trials Market replication Facilitate access to private finance Support via networking, training, coaching, knowledge sharing, etc

FP7 UK Technology Strategy Board Driving Innovation Phase 1 Concept & Feasibility Assessment Phase 2 Demonstration Market Replication R&D Phase 3 Commercialisation Funding: lump sum ~50,000 € Duration: approx. 6 months Call always open Time to contract: 60 – 90 days Funding: 1 to 3 € million (output based payments) Duration: approx months Call always open Time to contract: 150 days No direct funding Support and facilitate access to private finance: financing instruments New SME instrument

FP7 UK Technology Strategy Board Driving Innovation Horizon 2020 structure Opportunities for SMEs Facts and figures NCP support Agenda

FP7 UK Technology Strategy Board Driving Innovation Year Total Funding Projects Funded Topics SME Targeted 2007€641 million153870% 2008€577 million172870% 2009€593million108710% 2010€628 million131720% 2011€657 million % 2012€657 million % 2013€819 million*~ % Facts and figures FP7 Health Theme Funding,

FP7 UK Technology Strategy Board Driving Innovation UK has highest level of participation in successful health projects Facts and figures FP7 Health Theme – Participants

FP7 UK Technology Strategy Board Driving Innovation UK organisations have secured > €550 million of EU funding for Health research Facts and figures FP7 Health Theme – EC contribution (€ M)

FP7 UK Technology Strategy Board Driving Innovation International contacts, new collaborations and long term partnerships were developed New customers were identified New skills and knowledge were developed and expertise was extended Commercially exploitable new products or services were developed New projects were initiated from the results Publicity was created for the company Interest was generated from investors Facts and figures FP7 Health Theme – Inputs from participants

FP7 UK Technology Strategy Board Driving Innovation Horizon 2020 structure Opportunities for SMEs Facts and figures NCP support Agenda

FP7 UK Technology Strategy Board Driving Innovation All advice is confidential, impartial and free A UK-wide network provided by the Technology Strategy Board to help you engage with H2020 General advice on H2020 participation – help you to make an informed decision (signposting) Helpline - scientific priorities, calls, participation rules, financial rules, partnering… Follow-on advice – negotiation stage, reports, cost claims, IPR, project management… Informing and Awareness Raising (Infodays, seminars,…) NCP support

FP7 UK Technology Strategy Board Driving Innovation _Connect NCP contacts Information News Events Documents Network NCP support

FP7 UK Technology Strategy Board Driving Innovation EU networks: Health NCP Net Fit for Health Health-2- Market NCP meetings NCP support

FP7 UK Technology Strategy Board Driving Innovation Cordis: Participant portal: Register as an expert: Fit for Health: Health 2 Market: Health project database: UK support: NCP support Further information

FP7 UK Technology Strategy Board Driving Innovation Website: E mail: Phone: Mobile: Alternative: Victoria Brewer FP7 Health National Contact Point: Octavio Pernas